Deep Genomics is based in Toronto, Canada. It has raised $180M in total funding. Latest round: Series C.
Deep Genomics is based in Toronto, Canada. Deep Genomics has raised $180M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in July 2021. The round record for Deep Genomics runs through 2021; nothing later has been disclosed. Investors on record include SoftBank Vision Fund 2, CPP Investments, Fidelity Management & Research Company LLC, Alexandria Venture Investments, Amplitude Ventures, Khosla Ventures and 2 others. 8 distinct backers are named across the disclosed rounds.
Deep Genomics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Toronto below to benchmark round size and investor mix.
The investor deck Deep Genomics used to raise — 2021, Series C, 16-slide deck is broken down slide by slide, including the slides it leads with and the questions it leaves open.
Company funding database · Investor directory · Founder database · Mega-rounds 2026